NetworkNewsBreaks – Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) Enters Strategic Agreement with Israel-Based Fantasy Network Ltd.
Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) this morning announced its entry into a strategic business cooperation agreement with Fantasy Network Ltd. (TASE: FNTS) of Tel Aviv, Israel. Under the agreement, the companies will form the foundation to joint venture business opportunities in the Israeli medical cannabis sector. The signed agreement provides Redfund a framework to access Fantasy’s currently-controlled projects, as well as those under negotiation primarily in Israel. In addition, Redfund will assist Fantasy in licensing patented Israeli medical technology and cannabis delivery systems outside of Israel and provide capital, alongside Fantasy, to medical cannabis businesses. “Israel is home to novel cannabis drug delivery devices, patented grow and planting technologies, holistic cannaceuticals and pharma-grade medical cannabis,” Redfund CEO Meris Kott said in the news release. “The people and companies I was introduced to during my trip to Tel Aviv, assures me that Redfund’s partnership with Fantasy will be a lucrative relationship for both our stakeholders. Redfund is already in discussions to bring Israel medical cannabis based companies global with Israeli licensing agreements with Canadian Licensed Producers and distribution contracts in other countries where medical cannabis is legalized.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) this morning announced its entry into a strategic business cooperation agreement with Fantasy Network Ltd. (TASE: FNTS) of Tel Aviv, Israel. Under the agreement, the companies will form the foundation to joint venture business opportunities in the Israeli medical cannabis sector. The signed agreement provides Redfund a framework to access Fantasy’s currently-controlled projects, as well as those under negotiation primarily in Israel. In addition, Redfund will assist Fantasy in licensing patented Israeli medical technology and cannabis delivery systems outside of Israel and provide capital, alongside Fantasy, to medical cannabis businesses. “Israel is home to novel cannabis drug delivery devices, patented grow and planting technologies, holistic cannaceuticals and pharma-grade medical cannabis,” Redfund CEO Meris Kott said in the news release. “The people and companies I was introduced to during my trip to Tel Aviv, assures me that Redfund’s partnership with Fantasy will be a lucrative relationship for both our stakeholders. Redfund is already in discussions to bring Israel medical cannabis based companies global with Israeli licensing agreements with Canadian Licensed Producers and distribution contracts in other countries where medical cannabis is legalized.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
